Chemical constituents from Munronia sinica and their bioactivities
Abstract
Two new minor constituents, musinisins A(1) and B(2), together with five known compounds(3-7), were isolated from the aerial parts of Munronia sinica. Their structures were established by means of spectroscopic methods and the absolute stereochemistry of 1 was determined by single crystal X-ray experiment. Compound 4 showed antiangiogenic activity evaluated by a zebrafish model and apoptosis-inducing effect on A549 lung cancer cells.Keywords
Munronia sinica chemical constituent musinisin antiangiogenic activityIntroduction
The genus of Munronia (Meliaceae) is composed of about 15 species in the world, and 8 species of them were distributed in China.1 Up to now, some phytochemical studies have been reported on M. delavayi2-5 and M. henryi6-9, and tetranortriterpenoids and triterpenoids are their main components. Especially, tetranortriterpenoids exhibit chemical defensive function in nature, such as antibacterium, antifungal, 2 and antifeeding8 activities. M. sinica Diels grows in Jinfoshan of Sichuan, which is low subshrubs and an endemic species of China. To the date, no chemical research has been published about this species. In this paper, we reported the isolation and structure elucidation of two new compounds, musinisins A (1) and B (2), together with five known compounds, including glucoacetosyringone (3), 10 6, 7-bis(acetyloxy)-4, 4, 8-trimethyl-3-oxo-(5α, 6α, 7α, 13α, 17α, 20ξ)-carda-1, 14-dienolide (4), 11 cannabiside D (5), 12 corchoionoside C (6), 13 (+)-3-oxo-α-ionyl glucoside (7).14 Compounds 1–7 were tested for their antiangiogenic activities using a zebrafish model and the antiproliferative activities using A549 lung cancer cells.
The structures of compounds 1–7
Results and Discussion
A 70% aqueous acetone extract prepared from the leaves and stems of M. sinica was partitioned between EtOAc and H2O. The EtOAc layer was subjected repeatedly to column chromatography on silica gel, Sephadex LH-20, and RP-18, to afford compounds 1–7. Their structures were shown in Figure 1, and 1H and 13C NMR spectroscopic data were listed in Tables 1 and 2.
The NMR (DMSO-d6, δ in ppm, J in Hz) data of 1
The NMR (100 MHz, DMSO-d6, δ in ppm, J in Hz) data of 2
Compound 1 was obtained as colorless crystals. Its molecular formula, C14H26O8, was established on the basis of HRESIMS analysis ([M – H]–, m/z 321.1543, calcd 321.1549) and its 1H and 13C NMR spectra. Analysis of the 1H and 13C NMR (Table 1), HSQC and HMBC spectra of 1 revealed the presence of 14 carbons, including one carboxylic acid group (δC 175.7), one i-pr group (δC 27.6, 19.4, 18.1), one methyl (δC 21.4), one methylene (δC 31.3), two methines (δC 44.7 and 75.9), and one hexose (δC 102.8, 76.9, 76.9, 73.9, 70.3, 61.3). In the 1H-1H COSY spectrum (Figure 2), the correlation of H-2/H-3/H-4/Me-5 was observed, which established the direct connections of C-2, C-3, C-4 and C-5. The i-pr group locating at C-3 (δC 44.7) was determined by the HMBC correlations of H-3 (δH 1.87, m) with the carbon signals at δC 27.6 (C-1′) and 19.4 (C-2′) of i-pr group and 1H-1H COSY correlation of H-3 with H-1′ (Figure 2). The linkage position of the hexose moiety was located at C-4 (δC 75.9) of its aglycone by the HMBC correlations of the anomeric proton at δH 4.13 with C-4. The anomeric center of the sugar moiety was determined to be β-configuration from the large 3 JH1″-H2″ value (J = 7.8 Hz). Furthermore, we get a suitable crystal and the X-ray experiment was conducted using an anomalous dispersion with copper radiation (Figure 3), which not only determined the hexose to be D-glucose, but also established the absolute stereochemistry of 1. In combination with IUPAC sequence rule, 15 the configuration of C-3 and C-4 were deduced as R and S, respectively. Thus, the structure of 1 was established as (3R, 4S)-3-isopropyl-4-hydroxypentanoic acid 4-O-β-D-glucopyranoside and given the name of musinisin A. The plausible biogenetic pathway of 1, starting from, 3-isopropyl-4-methylcyclohexene was also discussed (Scheme 1).
Key HMBC (→) and 1H-1H COSY (━) correlations of 1 and 2
X-ray structure of 1 showing absolute configuration
Hypothetical biogenetic pathway of 1
Compound 2 was isolated as yellow powder with [α]]D19.9 – 54.86 (c 0.14, MeOH). The molecular formula, C16H24O9, was deduced by HRESIMS ([M + Cl]– at m/z 395.1100; calcd 395.1108), with five degrees of unsaturation. The 1H NMR spectrum (Table 2) showed signals for two methoxyl groups. Comparison of the 1D and 2D NMR data of 2 with those of known compound glucoacetosyringone (3)10 revealed that compound 2 was structurally similar to 3. The differences were resulted from the appearance of an oxygenated methine signal (δC 68.2, CH; δH 4.6, m), and the lack of a carbonyl signal in 2. This indicated that the carbonyl group at C-7 in 3 was replaced by an oxygenated methine group in 2, which was confirmed by the HMBC correlations of H-2 (δH 6.62), H-6 (δH 6.62) and Me-8 (δH 1.30) with C-7 (δC 68.2) and the 1H-1H COSY correlation of H-7/Me-8 (Figure 2). Acid hydrolysis of 2 (5 mg) in 2 M HCl (3 mL) provided a D-glucose and an aglycone (C10H14O4, an amorphous powder, [α]D19.9 –4.63). The glycosyl group was detected by TLC comparison with authentic sample using CHCl3-MeOH (8:2) as a developing system (Rf = 0.16). The anomeric center of the glucose moiety was determined to be β-configuration from the large 3JH1′-H2′ value (J = 7.3 Hz). As the aglycone showed a negative optical rotation value that was opposite to that of (1R)-1-phenyl-1-propanol, 16 the absolute configuration at C-7 of 2 was suggested to be S. Thus, the structure of 2 was established and given the trivial name musinisin B.
The antiangiogenic activities of compounds 1, 2, 4, 5 and 7 were evaluated using a zebrafish model, in terms of the inhibition on the growth of intersegmental vessels, with PTK787 as positive control (IC50 0.15 μg/mL).17 The results showed that intersegmental vessels of embryos treated with 4 was significantly less than that of the control (0.1% DMSO in sterile salt water). The inhibition ratio of 4 was 58.7% at a concentration of 40 μg/mL (Table 3). The antiproliferative activities of compounds 1–7 were evaluated using A549 lung cancer cells by MTT assay.18 The results indicated that compounds 1, 2, 4 and 7 showed a certain extent antiproliferative activities (Table 4). From the photos of acridine orange staining, compound 4 showed obvious effect of inducing apoptosis of A549 lung cancer cells (Figure 4).
Antiangiogenic activity of compounds 1, 2, 4, 5 and 7
Inhibitory effect of compounds 1, 2, 4, and 7 on the proliferation of A549 lung cancer cells
Photos of acridine orange staining
Experimental Section
General Experimental Procedures. Melting point was obtained on an XRC-1 micro melting point apparatus and is uncorrected. Optical rotations were measured with a Jasco P-1020 polarimeter. UV spectra were obtained using a Shimadzu UV-2401A spectrophotometer. A Bruker Tenor 27 spectrophotometer was used for scanning IR spectroscopy with KBr pellets. 1D and 2D NMR spectra were recorded on Bruker DRX-500 spectrometers. Unless otherwise specified, chemical shifts (δ) were expressed in ppm with reference to the solvent signals. Mass spectra were performed on an API QSTAR Pulsar i spectrometer. Column chromatography was performed with silica gel (200–300 mesh, Qingdao Marine Chemical, Inc., Qingdao, China). Fractions were monitored by TLC and spots were visualized by heating silica gel plates sprayed with 10% H2SO4 in EtOH.
Plant Material. The aerial parts of M. sinica were collected in Jinfoshan Mountain of Sichuan Province, China, in August 2008. The specimen was identified by Prof. Yong-Ping Yang and a voucher specimen (ChenYu-200801) has been deposited at the Institute of Tibetan Plateau Research at Kunming, Kunming Institute of Botany, Chinese Academy of Sciences.
Extraction and Isolation. The dried aerial parts of M. sinica (8.0 kg) were powdered and extracted with 70% aqueous Me2CO (15 L × 4) for 48 hours at room temperature and filtrated. The filtrate was concentrated and partitioned with EtOAc. The EtOAc portion was subjected to column chromatography over MCI gel eluting with 95% EtOH and concentrated in vacuo. The residue (190 g) was chromatographed on silica gel column eluting with CHCl3-MeOH (1:0, 9:1, 8:2, 2:1, 1:1, and 0:1) to afford fractions Ⅰ–Ⅵ. Fraction Ⅱ (9:1) was repeatedly chromatographed on silica gel (200–300 mesh) and Sephadex LH-20 to yield compounds 1(10 mg), 2 (15 mg), 3 (8 mg), 4 (20 mg), 5 (18 mg), 6 (18 mg), and 7 (13 mg).
Musinisin A (1): colorless crystal; mp 150–151 ℃; [α]D19.8 – 23.95 (c 0.35, MeOH); IR (KBr) νmax 3490, 3347, 2985, 2901, 1698, 1430, 1403, 1282, 1201, 1102, 1036, 1015, 939, 637 cm–1; 1H and 13C NMR data see Table 1; negative ion ESIMS m/z 321 [M – H]–; HRESIMS m/z 321.1543 (calcd for C14H25O8 [M – H]–, 321.1549).
Musinisin B (2): yellow powder; [α]D19.9 –54.86 (c 0.14, MeOH); IR (KBr) vmax 3546, 3476, 3396, 3277, 2979, 2914, 1598, 1462, 1425, 1327, 1130, 1068 cm–1; 1H and 13C NMR data see Table 2; negative ion ESIMS m/z 395 [M + Cl]–; HRESIMS m/z 395.1100 (calcd for C16H24O9Cl [M + Cl]–, 395.1108).
Crystallographic data for 1: C14H26O8, M = 322.36, orthorhomic, space group P212121, a = 7.2561(4) Å, b = 9.5748(5) Å, c = 23.2846(14) Å, α=β=γ= 90°, V = 1617.71(16) Å3, Z = 4, d = 1.373 g cm-3, crystal size 0.30 mm × 0.52 mm × 0.54 mm, was used for measurements on a Bruker APEX DUO diffractometer with a graphite monochromator, Cu Kα radiation. The total number of independent reflections measured was 2753, of which 2740 were observed (|F|2≥2σ|F|2). Final indices: R1 = 0.0363, wR2 =0.0920 (w = 1/σ|F|2). The crystal structure of 1 were solved and refined by the direct method SHELX-97 (Sheldrich, G. M. University of Gottingen: Gottingen, Germany, 1985). Crystallographic data for the structure of 1 has been deposited in the Cambridge Crystallographic Data Centre (deposition number: CCDC 853392). Copies of this data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB21EZ, UK; fax: (+44) 1223-336-033; or deposit@ccdc.cam.ac.uk).
Acid Hydrolysis of 2. A solution of 2 (5 mg) in 2 M HCl (3 mL) was heated in a water bath at 70 ˚C for 6 h. After cooling, the reaction mixture was neutralized with NaHCO3 and extracted with CHCl3. Through TLC comparison with authentic sample using CHCl3-MeOH (8:2) as a developing system, Dglucose was detected in the water layer (Rf = 0.16). The aqueous solution was further concentrated to dryness and subjected to a silica gel chromatography eluting with CHCl3-MeOH (9:1) to give D-glucose (1 mg), [α]D18 + 40 (c 0.2, MeOH). The CHCl3 fraction was further subjected to a silica gel chromatography eluting with petroleum ether-EtOAc (4:1) to afford the aglycone (1.2 mg), [α]D19.9 –4.63 (c 0.17, MeOH).
Antiangiogenesis Bioassay. Stock solutions (10 mg/mL) of all samples were prepared by dissolving the test compounds in 100% DMSO. These solutions were diluted in sterile salt water (5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl2, and 0.16 mM MgSO4) to obtain solutions with the test compounds dissolved in 0.1% DMSO. These solutions were aliquot into 96-well plates, and embryos at 24 hpf (hours post fertilization) were also transferred randomly into the above wells. After 24h of treatment, the intersegmental vessels of embryos were visualized with green fluorescent protein labeling and endogenous alkaline phosphatase staining. The antiangiogenic activities of compounds were calculated from the inhibition ratio of angiogenesis. PTK787 was used as the positive control.
Antiproliferative Bioassay. A549 lung cancer cells were cultured in RPMI 1640 medium at 37 oC with 5% CO2 and 95% air, supplemented with 10% (v/v) bovine calf serum and 80 U/ml penicillin/streptomycin. The cells were seeded onto 96-well plates and treated with compounds at 3, 10, 30 and 100 μg/mL for 48h, respectively. Cell viability was determined by MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium) assay. The light absorption was measured at 570 nm using Spectra MAX 190 microplate spectrophotometer (GMI Co., USA). Inhibition rate was calculated by the formula:
Inhibition (%) = 100% – (OD treatment – OD blank)/(OD control – OD blank) × 100%
The cells were incubated with compounds (100 μg/mL) for 48 h, and stained with 0.1 mg/ml of acridine orange (AO) at room temperature for 5 min. Then the cells were observed and photographed using the fluorescent stereo microscope (Olympus, Japan).
Notes
Electronic Supplementary Material
Supplementary material is available in the online version of this article at http://dx.doi.org/10.1007/s13659-012-0001-8 and is accessible for authorized users.
Acknowledgments
This project was supported financially by the Bureau of Science and Technology of Kunming City.
References
- 
                            1.Yunnan Institute of Botany, Flora Yunnanica; Science Press:Beijing, 1977; Tomus. 1. pp 214-216. PubMed Google Scholar
 - 
                            2.B. D. Lin, H. D. Chen, J. Liu, S. Zhang, Y. Wu, L. Dong, J. M. Yue, Phytochemistry 71, 1596-1601 (2010) CrossRef PubMed Google Scholar
 - 
                            3.X. H. Cai, X. D. Luo, Chin. J. Chem. 25, 986-988 (2007) CrossRef PubMed Google Scholar
 - 
                            4.X. H. Cai, Z. Z. Du, X. D. Luo, Helv. Chim. Acta 90, 1980-1986 (2007) CrossRef PubMed Google Scholar
 - 
                            5.X. H. Cai, X. D. Luo, J. Zhou, X. J. Hao, J. Integ. Plant Biol. 48, 1126-1128 (2006) CrossRef PubMed Google Scholar
 - 
                            6.H. P. Zhang, G. H. Bao, H. B. Wang, G. W. Qin, Nat. Prod. Res. 18, 415-419 (2004) CrossRef PubMed Google Scholar
 - 
                            7.S. H. Qi, D. G. Wu, Y. B. Ma, X. D. Luo, J. Asian Nat. Prod. Res. 5, 215-221 (2003) CrossRef PubMed Google Scholar
 - 
                            8.S. H. Qi, L. Chen, D. G. Wu, Y. B. Ma, X. D. Luo, Tetrahedron 59, 4193-4199 (2003) CrossRef PubMed Google Scholar
 - 
                            9.S. H. Qi, D. G. Wu, L. Chen, Y. B. Ma, X. D. Luo, J. Agr. Food Chem. 51, 6949-6952 (2003) CrossRef PubMed Google Scholar
 - 
                            10.T. Itoh, M. Ninomiya, Y. Nozawa, M. Koketsu, Bioorg. Med. Chem. 18, 7052-7057 (2010) CrossRef PubMed Google Scholar
 - 
                            11.J. D. Connolly, C. Labbe, S. Rycroft, D. A. H. Taylor, J. Chem. Soc. Perkin Trans. 1, 2959-2964 (1979) PubMed Google Scholar
 - 
                            12.B. Wu, W. Li, W. H. Lin, H. Y. Gao, L. J. Wu, Z. S. Jin, Chin. J. Med. Chem. 15, 178-179 (2005) PubMed Google Scholar
 - 
                            13.M. Yoshikawa, H. Shimada, M. Saka, S. Yoshizumi, J. Yamahara, H. Matsuda, Chem. Pharm. Bull. 45, 464-469 (1997) CrossRef PubMed Google Scholar
 - 
                            14.B. Cui, M. Nakamura, J. Kinjo, T. Nohara, Chem. Pharm. Bull. 41, 178-182 (1993) CrossRef PubMed Google Scholar
 - 
                            15.IUPAC Nomenclature of Organic Chemistry, Pergamon:New York, 1979, Sections A-H. Recommendation for section A, Spiro hydrocarbons. PubMed Google Scholar
 - 
                            16.T. Ishikawa, K. Kondo, J. Kitajima, Chem. Pharm. Bull. 51, 32-39 (2003) CrossRef PubMed Google Scholar
 - 
                            17.X. L. Li, Y. Li, S. F. Wang, Y. L. Zhao, K. C. Liu, X. M. Wang, Y. P. Yang, J. Nat. Prod. 72, 1001-1005 (2009) CrossRef PubMed Google Scholar
 - 
                            18.Q. X. He, X. S. Zhu, M. Shi, B. X. Zhao, J. Zhao, S. L. Zhang, J. Y. Miao, Bioorg. Med. Chem. 15, 3889-3895 (2007) CrossRef PubMed Google Scholar
 
Copyright information
© The Author(s) 2012
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

								
								





